LMR Partners LLP lowered its stake in shares of Albemarle Co. (NYSE:ALB) by 45.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,083 shares of the specialty chemicals company’s stock after selling 7,680 shares during the period. LMR Partners LLP’s holdings in Albemarle were worth $1,238,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Carroll Financial Associates Inc. lifted its holdings in shares of Albemarle by 0.3% during the 2nd quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock valued at $103,000 after purchasing an additional 3 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Albemarle by 0.3% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,458 shares of the specialty chemicals company’s stock valued at $154,000 after purchasing an additional 4 shares during the last quarter. Scotia Capital Inc. lifted its holdings in shares of Albemarle by 0.5% during the 2nd quarter. Scotia Capital Inc. now owns 2,022 shares of the specialty chemicals company’s stock valued at $213,000 after purchasing an additional 10 shares during the last quarter. Alps Advisors Inc. lifted its holdings in shares of Albemarle by 0.3% during the 2nd quarter. Alps Advisors Inc. now owns 4,606 shares of the specialty chemicals company’s stock valued at $486,000 after purchasing an additional 12 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Albemarle by 2.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock valued at $102,000 after purchasing an additional 20 shares during the last quarter. Institutional investors own 87.10% of the company’s stock.

Several analysts have recently commented on ALB shares. Oppenheimer Holdings, Inc. increased their price objective on Albemarle from $133.00 to $157.00 and gave the company an “outperform” rating in a report on Monday, October 16th. Deutsche Bank AG lowered Albemarle from a “buy” rating to a “hold” rating in a report on Tuesday, November 14th. BMO Capital Markets started coverage on Albemarle in a report on Tuesday, October 24th. They set an “outperform” rating and a $160.00 price objective for the company. Zacks Investment Research upgraded Albemarle from a “hold” rating to a “buy” rating and set a $157.00 price objective for the company in a report on Tuesday, October 17th. Finally, Instinet reiterated a “buy” rating and set a $154.00 price objective (up previously from $146.00) on shares of Albemarle in a report on Friday, October 13th. Nine equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $128.45.

Albemarle Co. (NYSE:ALB) opened at $137.06 on Friday. The stock has a market capitalization of $14,944.53, a price-to-earnings ratio of 33.48, a P/E/G ratio of 2.05 and a beta of 1.72. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.56. Albemarle Co. has a 52 week low of $83.10 and a 52 week high of $144.99.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.01. The company had revenue of $755.00 million during the quarter, compared to analyst estimates of $732.19 million. Albemarle had a return on equity of 11.61% and a net margin of 30.07%. The firm’s quarterly revenue was up 15.4% on a year-over-year basis. During the same quarter last year, the business posted $0.91 EPS. analysts forecast that Albemarle Co. will post 4.47 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 2nd. Investors of record on Friday, December 15th will be paid a $0.32 dividend. The ex-dividend date is Thursday, December 14th. This represents a $1.28 dividend on an annualized basis and a yield of 0.93%. Albemarle’s dividend payout ratio (DPR) is 16.56%.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://www.watchlistnews.com/lmr-partners-llp-has-1-24-million-holdings-in-albemarle-co-alb/1725516.html.

About Albemarle

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB).

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Receive News & Ratings for Albemarle Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.